Back to results
US 2009/0221835 A1Published application
Processes for preparing biaryl ureas and analogs thereof
AssigneeVertex Pharmaceuticals Incorporated
InventorsGraham Ansell, Todd Blythe, Andrew Jones, Benjamin Littler, Adam Looker, Philip Nyce, John Snoonian
Life of this patent
Estimating the term…
Abstract
The present invention relates to processes for preparing biaryl ureas derivatives and analogs thereof. The invention also provides compounds useful as intermediates in the processes of the present invention. The process is useful for preparing compounds that inhibit IMPDH.
Claims22
1-21. (canceled)
A process for preparing a compound of formula II:
- comprising the steps of:
- (a) converting a compound of formula V:
- under suitable catalytic hydrogenation conditions to give a compound of formula IV:
- or a salt thereof, and
- (b) reacting said compound of formula IV with a compound of formula LGC(O)X1, under suitable conditions, wherein:
- X1 is a halogen;
- LG is —OR16;
- wherein R16 is —(C1-C6)-straight or branched alkyl;
- —(C2-C6)-straight or branched alkenyl or alkynyl;
- or a monocyclic ring system consisting of 5 to 6 members per ring, wherein said ring system optionally comprises up to 3 heteroatoms selected from N, O, or S, and each R16 optionally comprises up to 5 substituents independently selected from (C1-C4)-straight or branched alkyl, (C2-C4) straight or branched alkenyl, or (CH2)n-Z;
- wherein Z is selected from halogen, CN, NO2, CF3, OCF3, OH, S(C1-C4)-alkyl, SO(C1-C4)-alkyl, SO2(C1-C4)-alkyl, NH2, NH(C1-C4)-alkyl, N((C1-C4)-alkyl)2, COOH, C(O)O(C1-C4)-alkyl or O(C1-C4)-alkyl;
- n is 0, 1, 2, 3, or 4;
- y is zero;
- R1 or R2 is selected from hydrogen, methyl ethyl or phenyl;
- and the other of R1 or R2 is selected from —CH2OH, —CH2CN, —CH2CH CN, or —CH2N(CH2CH3)2;
- or wherein R1 and R2 are taken together to form a 3-tetrahydrofuranyl moiety;
- R9 is hydrogen, (S)-methyl, (S)-ethyl or (S)-hydroxymethyl;
- R10 is selected from —C≡N or 5-oxazolyl;
- R11 is methoxy, ethoxy or isopropoxy;
- each V1 is independently selected from halogens NO2, CN, OR12, OC(O)R13, OC(O)R12, OC(O)OR13, OC(O)OR12, OC(O)N(R13)2, OP(O)(OR13)2 SR13, SR12, S(O)R13, S(O)R12, SO2R13, SO2R12, SO2N(R13)2, SO2NR12R13, SO3R13, C(O)R12, C(O)OR12C(O)R13, C(O)OR13, NC(O)C(O)R13, NC(O)C(O)R12, NC(O)C(O)OR13, NC(O)C(O)N(R13)2, C(O)N(R13)2, C(O)N(OR13)R13, C(O)N(OR13)R13, C(NOR12)R13COR13)R13, N(R12, N(R13)2, NR13C(O)R12, NR13C(O)R13, NR13C(O)R12NR13, C(O)OR13NR13C(O)OR12, NR13C(O)N(R13)2, NR13C(O)NR12R13, NR13SO2R13, NR13SO2R12, NR13SO2N(R13)2, NR13SO2R12R13, N(OR)R13, N(OR13)R12, P(O)(OR13)N(R13)2, and P(O)(OR13)2;
- wherein each R12 is a monocyclic or a bicyclic ring system consisting of 5 to 6 members per ring wherein said ring system optionally comprises up to 4 heteroatoms selected from N, O, or S, and wherein a CH2 adjacent to said N, O or S may be substituted with C(O);
- and each R12 optionally comprises up to 3 substituents selected from R11;
- wherein each R13 is independently selected from H, (C1-4)-straight or branched alkyl or (C2-C4) straight or branched alkenyl;
- and
- wherein each R13 optionally comprises a substituent that is R14;
- wherein R14 is a monocyclic or a bicyclic ring system consisting of 5 to 6 members per ring, wherein said ring system optionally comprises up to 4 heteroatoms selected from N, O or S, and wherein a CH2 adjacent to said N, O or S maybe substituted with C(O);
- and each R14 optionally comprises up to 2 substituents independently chosen from H, (C1-C4)-straight or branched alkyl or (C2-C4) straight or branched alkenyl 1,2-methylenedioxy, 1,2-ethylenedioxy, or (CH2)n-Z;
- wherein Z is selected from halogen CN, N2, CF3 oCF3, OH, S(C1-C4) alkyl, SO(C1-C4)-alkyl SO2(C1-C4)-alkyl NH2, NH(C1-C4-alkyl N((C1-C4)-alkyl)2, COOH, C(O)O(C1-C4)-alkyl or O(C1-C4)-alkyl;
- and
- wherein any carbon atom in any R13 is optionally replaced by O, S, SO, SO2 NH, or N(1-C4)-alkyl;
- and
- provided that R16 is not a halo-substituted (C2-C3)-straight alkyl.
29 more elements
(canceled)
A compound of formula Va:
- or a salt thereof, wherein:
- Q is NO2 or NH2;
- each of R1 and R2 is independently selected from hydrogen;
- —CF3;
- —(C1-C6)-straight or branched alkyl;
- —(C2-C6)-straight or branched alkenyl or alkynyl;
- —(C1-C6)-straight or branched alkyl-R7;
- —[(C2-C6)-straight or branched alkenyl or alkynyl]-R7 or —R7;
- and wherein at least one of R1 or R2 is —(C1-C6)-straight or branched alkyl-R7;
- —[(C2-C6)-straight or branched alkenyl or alkynyl]-R7 or —R7;
- wherein up to 4 hydrogen atoms in any of said alkyl, alkenyl or alkynyl are optionally and independently replaced by R3;
- or
- R1 and R2 are alternatively taken together to form a tetrahydrofuran ring, wherein up to 2 hydrogen atoms in said tetrahydrofuran ring are optionally replaced by —OR6 or —R7;
- each R3 is independently selected from halogen, CN, —OR4, or —N(R5)2;
- R4 is selected from hydrogen, —(C1-C6)-straight or branched alkyl, —(C2-C6)-straight or branched alkenyl or alkynyl, —[(C1-C6)-straight or branched alkyl]-R7, —[(C2-C6)-straight or branched alkenyl or alkynyl]-R7, —C(O)-[(C1-C6)-straight or branched alkyl], —C(O)-[(C2-C6)-straight or branched alkenyl or alkynyl], —C(O)-[(C1-C6)-straight or branched alkyl]-N(R8)2, —C(O)-[(C2-C6)-straight or branched alkenyl or alkynyl]-N(R8)2, —P(O)(OR8)2, —P(O)(OR8)(R8), —C(O)—R7, —S(O)2N(R5)2, —[(C1-C6)-straight or branched alkyl]-CN, or —[(C2-C6)-straight or branched alkenyl or alkynyl]-CN;
- wherein up to 4 hydrogen atoms in any of said alkyl, alkenyl or alkynyl are optionally and independently replaced by —C═O or Y;
- Y is selected from halogen, CN, NO2, CF3, OCF3, SR8, S(O)R8, SO2R8, NHR3, N(R8)2, COOR8 or OR8;
- each R5 is independently selected from hydrogen, —(C1-C6)-straight or branched alkyl, —(C2-C6)-straight or branched alkenyl or alkynyl, —[(C1-C6)-straight or branched alkyl]-R7, —[(C2-C6)-straight or branched alkenyl or alkynyl]-R7, —[(C1-C6)-straight alkyl]-CN, —[(C2-C6)-straight or branched alkenyl or alkynyl]-CN, —[(C1-C6)-straight or branched alkyl]-OR4, —[(C2-C6)-straight or branched alkenyl or alkynyl]-OR4, —C(O)—(C1-C6)-straight or branched alkyl, —C(O)-[(C2-C6)-straight or branched alkenyl or alkynyl], —C(O)—R7, —C(O)O—R7, —C(O)O—(C1-C6)-straight or branched alkyl, —C(O)O—[(C2-C6)-straight or branched alkenyl or alkynyl], —S(O)2—(C1-C6)-straight or branched alkyl, or —S(O)2—R7;
- or two R5 moieties, when bound to the same nitrogen atom, are taken together with said nitrogen atom to form a 3 to 7-membered heterocyclic ring, wherein said heterocyclic ring optionally contains 1 to 3 additional heteroatoms independently selected from N, O, S, S(O) or S(O)2;
- wherein up to 4 hydrogen atoms in any of said alkyl, alkenyl or alkynyl are optionally and independently replaced by —C═O or Y;
- R6 is selected from —C(O)—CH3, —CH2—C(O)—OH, —CH2—C(O)—O-tBu, —CH2—CN, or —CH2—C≡CH;
- each R7 is a monocyclic or bicyclic ring system wherein in said ring system:
- i. the ring comprises 5 to 7 ring atoms independently selected from C, N, O or S;
- ii. no more than 4 ring atoms are selected from N, O or S;
- iii. any CH2 is optionally replaced with C(O);
- iv. any S is optionally replaced with S(O) or S(O)2;
- and
- v. up to 3 hydrogen atoms in said monocyclic ring system are optionally replaced by V1;
- each R8 is independently selected from hydrogen, —(C1-C4)-straight or branched alkyl, or —(C2-C4)-straight or branched alkenyl;
- wherein up to 4 hydrogen atoms in any of said alkyl or alkenyl are optionally and independently replaced by halogen, CN, NO2, CF3, OCF3, SR17, S(O)R17, SO2R17, NHR17, N(R17)2, COOR17 or OR17;
- wherein R17 is selected from hydrogen, —(C1-C6)-straight or branched alkyl, —(C2-C6)-straight or branched alkenyl or alkynyl;
- R9 is selected from hydrogen, or —(C1-C6)-straight or branched alkyl or (C3-C6)-cycloaliphatic;
- wherein up to 4 hydrogen atoms in any of said alkyl, or cycloaliphatic are optionally and independently replaced by —C═O or Y;
- provided that;
- (a) when R1 is hydrogen and R2 is CH2Ph, then R9 is not CH2OR8, CH2CO2R8, CO2R8, CN, or C(O)NH2;
- and
- provided that the following compound are excluded;
- (b) methyl 2-(methoxycarbonyl)-1-(3-nitrophenyl) allylcarbamate;
- (c) methyl 2-hydroxy-1-(3-nitrophenyl)propylcarbamate;
- (d) allyl 2-(ethoxycarbonyl)-1-(3-nitrophenyl)ethylcarbamate;
- (e) ethyl cyano(3-nitrophenyl)methylcarbamate;
- and
- (f) ethyl 2-(ethoxycarbonyl)-1-(3-nitrophenyl)-3-oxobutylcarbamate.
40 more elements
Dependencies are inferred from the claim text.